# Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life

> **NCT01595724** · — · COMPLETED · sponsor: **Bayer** · enrollment: 3006 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Visanne (Dienogest, BAY86-5258)

## Key facts

- **NCT ID:** NCT01595724
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-07
- **Final completion:** 2015-05
- **Target enrollment:** 3006 (ACTUAL)
- **Last updated:** 2015-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01595724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01595724, "Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT01595724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*